SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-08-050081
Filing Date
2008-08-27
Accepted
2008-08-27 16:20:04
Documents
4
Period of Report
2008-08-21
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 v125052_8k.htm 8-K 58326
2 v125052_ex4-1.htm EX-4.1 68312
3 v125052_ex4-2.htm EX-4.2 195256
4 v125052_ex10-1.htm EX-10.1 40973
  Complete submission text file 0001144204-08-050081.txt   364816
Mailing Address 100 SOUTH MAIN STREET SUITE 300 DOYLESTOWN PA 18901
Business Address 100 SOUTH MAIN STREET SUITE 300 DOYLESTOWN PA 18901 267-880-1595
QUANTRX BIOMEDICAL CORP (Filer) CIK: 0000820608 (see all company filings)

IRS No.: 330202574 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-17119 | Film No.: 081042276
SIC: 3841 Surgical & Medical Instruments & Apparatus